Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - modifications
4
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Aberrant Post-translational
Modifications
(PTMs) in Methyl- and Propionic Acidemia and the Construction of a Novel Sirtuin (SIRT) Gene to Metabolize PTMs
Isolated Methylmalonic Acidemia (MMA) and the related disorder Propionic Acidemia (PA) comprise a relatively common and heterogeneous group of inborn errors of metabolism. NHGRI scientist discovered that in isolated MMA, a novel inhibitory PTM, methylmalonyllysine, is generated and inactivates protein targets through the failure of SIRT-mediated deacylation,...
Published: 10/28/2024
|
Inventor(s):
PamelaSara Head
,
Charles Venditti
Keywords(s):
Aberrant
,
Acidemia
,
Construction
,
Discovery
,
Ene
,
Metabolize
,
Methyl-
,
Modifications
,
Novel
,
Post-translational
,
Propionic
,
PTMs
,
Sirt
,
Sirtuin
,
VPXXXX
,
WIXXXX
,
WKXXXX
,
XEXXXX
Category(s):
TherapeuticArea > Endocrinology
,
TherapeuticArea > Dental
,
TherapeuticArea > Oncology
,
TherapeuticArea > Cardiology
,
TherapeuticArea > Ophthalmology
,
Application > Therapeutics
,
TherapeuticArea > Infectious Disease
,
Application > Research Materials
Broadly Neutralizing Antibodies Against HIV-1 Directed to the CD4 Binding Site of HIV Envelope Protein
Inhibiting the ability of HIV-1, the virus that causes AIDS, to infect cells is one approach to both prevention and treatment of HIV. Scientists at the NIAID Vaccine Research Center have isolated and characterized neutralizing antibodies (VRC01, 02, 03, and 07) that bind to the CD4 binding site of HIV-1 envelope glycoprotein gp120. These human monoclonal...
Published: 10/28/2024
|
Inventor(s):
Richard Wyatt
,
Xueling Wu
,
Yuxing Li
,
Carl-Magnus Hogerkorp
,
Mario Roederer
,
Zhi-yong Yang
,
Gary Nabel
,
Peter Kwong
,
Tongqing Zhou
,
Mark Connors
,
Gilad Ofek
,
Yongping Yang
,
Jiang Zhu
,
Lawrence Shapiro
,
William Schief
,
Rebecca Rudicell
,
Ivelin Georgiev
,
Young Do Kwon
,
Baoshan Zhang
,
Gwo-yu Chauang
,
Wei Shi
,
Gwo-Yu Chuang
,
John Mascola
Keywords(s):
Against
,
antibodies
,
Antibodies.
,
ANTIBODY
,
Antibody-based
,
B-Cells
,
Broadly
,
Chain
,
Constructs
,
CREATION
,
DA4AXX
,
DB4AXX
,
DC5AXX
,
DD2XXX
,
Epitope-Specific
,
Expressing
,
FUNCTION
,
Further
,
GENERAL
,
GLYCOPROTEIN
,
gp120
,
HIV
,
HIV-1
,
Identity
,
Immunoadesion
,
Immunoadhesin
,
Isolation
,
Listed LPM Thalhammer-Reyero as of 4/15/2015
,
MODE
,
Modifications
,
monoclonal
,
Monoco
,
Neutizing
,
Neutralization
,
Neutralizing
,
Novel
,
Patent Category - Biotechnology
,
Post LPM Assignment Set 20150420
,
Pre LPM working set 20150418
,
Probes
,
Single
,
Specific
,
VRC03
,
VRC03Isolation
Category(s):
Collaboration Sought > Licensing
,
Application > Therapeutics
,
Application > Vaccines
,
TherapeuticArea > Infectious Disease
,
Application > Diagnostics
,
Application > Research Materials
Viral Like Particles Based Chikungunya Vaccines
Chikungunya virus (CHIKV) is mosquito-borne alphavirus endemic in Africa, India, and Southeast Asia. In 2013 CHIKV infection has also emerged in the Caribbean and a pandemic of CHIKV has re-emerged in the Philippines following Typhoon Haiyan. Currently, there is no vaccine available for the prevention of CHIKV infection and no specific therapy exists...
Published: 10/28/2024
|
Inventor(s):
Wataru Akahata
,
Srinivas Rao
,
Gary Nabel
Keywords(s):
Against
,
ALPHA
,
ALPHAVIRUS
,
CAPSID
,
Chikungunya
,
CHIKV
,
DC5BXX
,
Development
,
DNA vaccine
,
E1
,
E1-E2
,
E2
,
Envelope
,
Generation
,
Method
,
MODIFICATION
,
Modifications
,
PARTICLES
,
Patent Category - Biotechnology
,
PLASMID
,
PREVENTIVE
,
production
,
Protein
,
proteins
,
Vaccine
,
VBXXXX
,
viral
,
virus
,
VIRUS-LIKE
,
VLPs
,
VLXXXX
,
XHXXXX
Category(s):
Collaboration Sought > Licensing
,
Application > Therapeutics
,
TherapeuticArea > Infectious Disease
,
Application > Vaccines
,
Application > Diagnostics
,
ResearchProducts > Research Equipment
Human DNA Polymerase Gamma for Testing the Effect of Drugs on Mitochondrial Function
One of the primary means for treating HIV infection is the use of antiviral nucleotide or nucleoside analogs. These analogs work by inhibiting the activity of reverse transcriptase, the enzyme responsible for preparing the HIV genome for integration into the DNA of the host cell. Although these analogs do not have an effect on the polymerases responsible...
Published: 10/28/2024
|
Inventor(s):
Rajesh Kasiviswanathan
,
Susan Lim
,
William Copeland
Keywords(s):
CLONE
,
DDXXXX
,
DEFICIENT
,
Directed
,
DNA
,
DXXXXX
,
Enzyme
,
EXONUCLEASE
,
Expression
,
Gamma
,
Human
,
Improved
,
Includes
,
Listed LPM Campbell as of 4/15/2015
,
Method
,
Modifications
,
polymerase
,
Polymerase.
,
Post LPM Assignment Set 20150420
,
Pre LPM working set 20150418
,
purification
,
recombinant
,
RXXXXX
,
SITE
,
TYPE
,
VLXXXX
,
Which
,
Wild
,
WIXXXX
,
XEXXXX
,
YBXXXX
Category(s):
Collaboration Sought > Collaboration
,
Application > Research Materials
,
TherapeuticArea > Infectious Disease
,
Application > Therapeutics